Form 4 holding
Chief Business Officer
Lycia Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 68,755
- Estimated value
- Report date
- 11 Aug 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount